Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04615091
Other study ID # 39512
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date August 30, 2020
Est. completion date August 2022

Study information

Verified date November 2020
Source Azienda Ospedaliera Universitaria Integrata Verona
Contact FEDERICO RAVAIOLI, MD; PhD
Phone +393333176759
Email f.ravaioli@unibo.it
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The ELASTO-SURGERY study aims to evaluate the prognostic role of portal hypertension evaluated by non-invasive methods in predicting post-operative morbidity (at 90 days) and mortality (at 365 days) in patients with advanced chronic liver disease undergoing elective extrahepatic surgery.


Description:

In the last years, the life expectancy of ACLD patients has increased due to the improvement of the therapeutic strategies of the complications of cirrhosis. .Although surgical procedures have become less invasive the mortality rate in ACLD patients undergoing extrahepatic surgery remains high. For these reasons, an accurate prediction of operative risk for patient-tailored surgical planning becomes crucial. Purpose of the study: To evaluate the prognostic role of portal hypertension by non- invasive methods in predicting post-operative complications in ACLD patients undergoing elective extrahepatic surgery. Study type: An international multicenter, prospective, uncontrolled observational study Study design: In cirrhotic patients undergoing extrahepatic surgery, within one month, a complete baseline evaluation is provided. Baseline evaluation (T0) includes: signature of informed consent, clinical history of liver disease, comorbidities and risk factors for hepato-biliary complications; complete laboratory tests; liver and spleen elastography (with Transient Elastography, ARFI or 2D-SWE). After surgery, each patient is evaluated at T1 (+90 days) with Elastography, laboratory tests, clinical examination and T2 (+ 365 days) by a clinical examination. Each center will prospectively collect data according to an electronic e-CFR on REDCap (Research Electronic Data Capture) system, a web application designed to support data capture for research studies in a secure manner. Study duration: The study period will last approx. 730 days, with a planned follow-up of 365 days after surgical intervention


Recruitment information / eligibility

Status Recruiting
Enrollment 250
Est. completion date August 2022
Est. primary completion date October 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age > 18 yrs; - Advanced chronic liver disease (LSM>10 kPa) - Any etiology (viral, metabolic, alcoholic, cholestatic and autoimmune); - Elective extrahepatic surgery planned within three months and requiring regional or general anaesthesia; - Patients are willing and able to give informed consent Exclusion Criteria: - Presence of hepatic decompensation at the time of informed consent or previous events of hepatic decompensation during the last three months before enrollment. - Presence of portal vein thrombosis - Previous placement of TIPS, - Prior liver transplantation, - Surgical resection or shunt. - Presence of active HCC that needed treatment at the time of informed consent

Study Design


Locations

Country Name City State
Austria Medical University of Vienna Vienna
Canada University of Alberta Hospital Edmonton
Canada McGill University Health Centre Montréal
Denmark Odense University Hospital Odense
France University hospital of Angers Angers
France Hopital Jean Verdier Bondy
France Hôpital Jean Verdier Bondy
France Bordeaux University Hospital Bordeau
France Hôpital Beaujon Clichy
France Hospices Civils de Lyon Hopital Hotel Dieu Lyon
France Centre Hospitalier de Montpellier Montpellier
France hôpital Antoine-Béclère, Hôpitaux Universitaires Paris-Sud, Assistance Publique-Hôpitaux de Paris Paris
France Hôpital de la Pitié-Salpêtrière Paris
France Purpan Hospital Toulouse Toulouse
Germany University Hospital Leipzig Leipzig
Hong Kong The Chinese University of Hong Kong Hong Kong
Italy Clinica di Gastroenterologia ed Epatologia Ancona Ancona
Italy Gastroenterology Unit - Azienda Ospedaliera Universitaria Sant'Orsola - Malpighi Bologna
Italy Ospedale di Bolzano Bolzano
Italy Azienda ospedaliero-universitaria Careggi Firenze
Italy Policlinico di Milano Milan
Italy Policlinico di Modena Modena
Italy Gastroenterology Unit, University of Palermo Palermo
Italy Università Sapienza Roma
Italy A.O.U. Città della Salute e della Scienza di Torino Torino
Italy ASUGI Clinica Patologie del Fegato, Clinica Chirurgica Trieste
Italy Aoui Borgo Trento Verona VR
Korea, Republic of Hanyang University Guri Hospital Hanyang
Korea, Republic of Boramae Internal Medicine Seoul
Korea, Republic of Yonsei University College of Medicine Seoul
Spain Barcelona Hepatic Hemodynamic Lab. Liver Unit. Hospital Clinic. Barcelona Barcelona
Spain Hospital Universitario Puerta de Hierro Majadahonda Madrid
Switzerland Inselspital Bern
Switzerland Ente Ospedaliero Cantonale Lugano
United Kingdom UCL Sheila Sherlock London
United Kingdom Room Nottingham Digestive Diseases Centre BRU Nottingham
United States Yale New Haven Hospital New Haven Connecticut

Sponsors (1)

Lead Sponsor Collaborator
Azienda Ospedaliera Universitaria Integrata Verona

Countries where clinical trial is conducted

United States,  Austria,  Canada,  Denmark,  France,  Germany,  Hong Kong,  Italy,  Korea, Republic of,  Spain,  Switzerland,  United Kingdom, 

References & Publications (8)

Cescon M, Colecchia A, Cucchetti A, Peri E, Montrone L, Ercolani G, Festi D, Pinna AD. Value of transient elastography measured with FibroScan in predicting the outcome of hepatic resection for hepatocellular carcinoma. Ann Surg. 2012 Nov;256(5):706-12; discussion 712-3. doi: 10.1097/SLA.0b013e3182724ce8. — View Citation

Colecchia A, Montrone L, Scaioli E, Bacchi-Reggiani ML, Colli A, Casazza G, Schiumerini R, Turco L, Di Biase AR, Mazzella G, Marzi L, Arena U, Pinzani M, Festi D. Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis. Gastroenterology. 2012 Sep;143(3):646-654. doi: 10.1053/j.gastro.2012.05.035. Epub 2012 May 27. — View Citation

Colecchia A, Ravaioli F, Marasco G, Colli A, Dajti E, Di Biase AR, Bacchi Reggiani ML, Berzigotti A, Pinzani M, Festi D. A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease. J Hepatol. 2018 Aug;69(2):308-317. doi: 10.1016/j.jhep.2018.04.023. Epub 2018 May 3. — View Citation

Ma X, Wang L, Wu H, Feng Y, Han X, Bu H, Zhu Q. Spleen Stiffness Is Superior to Liver Stiffness for Predicting Esophageal Varices in Chronic Liver Disease: A Meta-Analysis. PLoS One. 2016 Nov 9;11(11):e0165786. doi: 10.1371/journal.pone.0165786. eCollection 2016. — View Citation

Marasco G, Colecchia A, Dajti E, Ravaioli F, Cucchetti A, Cescon M, Festi D. Prediction of posthepatectomy liver failure: Role of SSM and LSPS. J Surg Oncol. 2019 Mar;119(3):400-401. doi: 10.1002/jso.25345. Epub 2018 Dec 18. — View Citation

Newman KL, Johnson KM, Cornia PB, Wu P, Itani K, Ioannou GN. Perioperative Evaluation and Management of Patients With Cirrhosis: Risk Assessment, Surgical Outcomes, and Future Directions. Clin Gastroenterol Hepatol. 2020 Oct;18(11):2398-2414.e3. doi: 10.1016/j.cgh.2019.07.051. Epub 2019 Jul 31. Review. — View Citation

Reverter E, Cirera I, Albillos A, Debernardi-Venon W, Abraldes JG, Llop E, Flores A, Martínez-Palli G, Blasi A, Martínez J, Turon F, García-Valdecasas JC, Berzigotti A, de Lacy AM, Fuster J, Hernández-Gea V, Bosch J, García-Pagán JC. The prognostic role of hepatic venous pressure gradient in cirrhotic patients undergoing elective extrahepatic surgery. J Hepatol. 2019 Nov;71(5):942-950. doi: 10.1016/j.jhep.2019.07.007. Epub 2019 Jul 19. — View Citation

Uyei J, Taddei TH, Kaplan DE, Chapko M, Stevens ER, Braithwaite RS. Setting ambitious targets for surveillance and treatment rates among patients with hepatitis C related cirrhosis impacts the cost-effectiveness of hepatocellular cancer surveillance and substantially increases life expectancy: A modeling study. PLoS One. 2019 Aug 26;14(8):e0221614. doi: 10.1371/journal.pone.0221614. eCollection 2019. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Early post-surgical (at +90 days) complications after extrahepatic surgery Complications related to the surgical procedure and/or liver disease after the extrahepatic elective surgery 90 days after surgery
Secondary The liver-related events and overall survival at +90 days and + 360 days after extrahepatic surgery Liver-related events (decompensation, TIPS placement, liver transplantation) or death (liver e non-liver related) at 90 days 360 days from the elective extra-hepatic surgery 360 days after surgery
See also
  Status Clinical Trial Phase
Completed NCT05062564 - Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye N/A
Completed NCT05346588 - THRIVE Feasibility Trial Phase 3
Completed NCT03930784 - A Real-world Study to Examine the Relationship Between Simple Physical Functioning Tests, Complications and Recovery Following Abdominal Surgery.
Not yet recruiting NCT04430972 - Immune Responsiveness and Outcome After Aortic Valve Surgery (Measure)
Recruiting NCT04887415 - Respiratory Strength Training in Cardiac Surgical Patients N/A
Recruiting NCT05254262 - Multicenter National Trial of Clinical Results of Surgical Elderly Patients
Recruiting NCT03561376 - Zinc Oxide Versus Petrolatum Following Skin Surgery Early Phase 1
Recruiting NCT04967391 - Tumescence in HNC Skin Graft Reconstruction Phase 3
Recruiting NCT05155878 - Prognostic Factors in Periampullary Tumors and Cysts
Terminated NCT03757455 - ERAS Protocol in Pancreaticoduodenectomy and Total Pancreatectomy N/A
Completed NCT03793816 - Tonsillectomy Using BiZactâ„¢ - a Randomized Side-controlled Clinical Trial N/A
Completed NCT03246165 - Predictive Factors and Complications of Delirium
Withdrawn NCT04090918 - Novel Methods for Characterizing Patients With Post-operative Atrial Fibrillation Secondary to Abdominal Surgery
Completed NCT05373238 - Same Day Discharge After Laparoscopic Hysterectomy
Completed NCT03938584 - The Effect of Vitamin C on Wound Healing In Mandibular Fracture Patients N/A
Not yet recruiting NCT05046925 - PACU for Postoperative Care After Major Thoracic and Abdominal Surgery
Completed NCT04550156 - Evaluation of the Introduction of a Colorectal Bundle in Left Sided Colorectal Resections N/A
Not yet recruiting NCT04199208 - Does Prehabilitation Improve Outcome in Coloncancer Surgery? N/A
Completed NCT04257344 - Use of Wearables for Early Detection of Complications After Major Acute Abdominal Surgery
Active, not recruiting NCT03721471 - Outcome of Very Old Patients Admitted for Elective Major Surgery, the Effect of Frailty